4//SEC Filing
SYNERGY PHARMACEUTICALS, INC. 4
Accession 0001104659-17-043012
CIK 0001347613operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 5:08 PM ET
Size
9.9 KB
Accession
0001104659-17-043012
Insider Transaction Report
Form 4
Spigelman Melvin K
Director
Transactions
- Award
Stock Options
2017-06-28+62,500→ 509,614 totalExercise: $4.50From: 2018-06-28Exp: 2027-06-28→ Common Stock (62,500 underlying) - Award
Stock Options
2017-06-28+12,000→ 509,614 totalExercise: $1.40From: 2017-06-28Exp: 2019-11-20→ Common Stock (12,000 underlying) - Disposition to Issuer
Stock Options
2017-06-28−12,000→ 497,614 totalExercise: $1.40Exp: 2019-11-20→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011.
Documents
Issuer
SYNERGY PHARMACEUTICALS, INC.
CIK 0001347613
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001347613
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 5:08 PM ET
- Size
- 9.9 KB